ProteinQure Raises Series A Financing to Advance First AI-Designed Peptide Therapeutic into Clinical Trials by Jessica | May 28, 2025 Read more »
Nuvig Therapeutics Announces First Patient Dosed in Phase 2 CIDP Trial of NVG-2089 and Presentation of Phase 1 Data by Jessica | May 14, 2025 Read more »
Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 by Jessica | May 13, 2025 Read more »
Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway by Jessica | Apr 25, 2025 Read more »
Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG by Jessica | Apr 16, 2025 Read more »
